For Life Sciences and MedTech companies looking to expand to the United States, our U.S. Market Accelerator provides a customised pathway to successfully enter, scale, and expand in the U.S. market, tailored to the company’s stage of readiness and growth objectives. 

Whether you are in the early stages of market entry, scaling up, or looking to expand an already established presence, our programme adapts to meet your specific needs. 

1. For early-stage companies, our accelerator offers immersion into the vibrant ecosystems of Boston and Philadelphia, delivering a solid foundation in the U.S. healthcare landscape, including FDA regulatory and reimbursement practices. Participants receive strategic guidance on legal and operational aspects in the U.S., along with personalised introductions to industry experts and key opinion leaders. We also provide initial investor readiness preparation and access to local angel and VC communities, enabling companies to secure pilot projects, clinical trials, and early-stage investments. 
2. For companies looking to scale, the programme deepens these connections within the East Coast’s Life Sciences and MedTech sectors. We facilitate strategic business development to secure major clients and clinical partnerships, while providing advanced investor relations support, from targeted introductions to venture capitalists (VC) and strategic investors to comprehensive data room preparation, ensuring readiness for robust fundraising efforts. 
3. For more established companies seeking to expand their market presence, our services focus on integrating seamlessly into the U.S. ecosystems. This includes strategic guidance on forming long-term partnerships, establishing clinical trials, and optimising operations for market success. We offer ongoing investor engagement strategies, manage data rooms, and provide full-service support to prepare for substantial fundraising rounds, ensuring companies are well-positioned for sustained growth in the U.S. market.